Teleflex Inc (TFX)

237.06
NYSE : Health Care
Prev Close 237.06
Day Low/High 0.00 / 0.00
52 Wk Low/High 136.53 / 240.93
Avg Volume 249.10K
Exchange NYSE
Shares Outstanding 45.04M
Market Cap 10.67B
EPS 5.90
P/E Ratio 45.29
Div & Yield 1.36 (0.60%)

Latest News

Teleflex To Present At The 47th Annual Meeting Of The International Continence Society (

Teleflex To Present At The 47th Annual Meeting Of The International Continence Society ("ICS")

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for Critical Care, Urology and Surgery, will showcase its advanced bladder management product lines at the 47th ICS (Annual Meeting of the...

Teleflex Incorporated To Acquire NeoTract

Teleflex Incorporated To Acquire NeoTract

Teleflex Incorporated (NYSE: TFX) (the "Company" or "Teleflex") and NeoTract, Inc.

Teleflex To Present At The Morgan Stanley 15th Annual Global Healthcare Conference

Teleflex To Present At The Morgan Stanley 15th Annual Global Healthcare Conference

Liam Kelly, President and COO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 15 th Annual Global Healthcare Conference at the Grand Hyatt in New York City, Tuesday, September 12, 2017 at...

Teleflex Awarded Group Purchasing Contract With Vizient Inc. For Non-Tunneled Central Venous Catheters

Teleflex Awarded Group Purchasing Contract With Vizient Inc. For Non-Tunneled Central Venous Catheters

Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies for vascular access, has announced a new three year Product Category contract with Vizient Inc.

Teleflex Announces Quarterly Dividend

Teleflex Announces Quarterly Dividend

Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.

Teleflex Reports Second Quarter 2017 Results

Teleflex Reports Second Quarter 2017 Results

Teleflex Incorporated (NYSE: TFX) (the "Company") today announced financial results for the second quarter ended July 2, 2017.

Arrow® Seldinger Arterial Catheterization Device Receives FDA Market Clearance

Arrow® Seldinger Arterial Catheterization Device Receives FDA Market Clearance

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced today that its Arrow ® Seldinger Arterial Catheterization Device received market...

Teleflex Announces Second Quarter 2017 Earnings Conference Call Information

Teleflex Announces Second Quarter 2017 Earnings Conference Call Information

Teleflex Incorporated (NYSE: TFX) announced today that financial results for the second quarter 2017 will be released before market open on Thursday, August 3, 2017.

Teleflex's (TFX) Vascular Solutions, Inc. Issues Recall Of Venture® Catheters

Teleflex Incorporated (NYSE: TFX), announces a worldwide recall of Venture ® Catheters was voluntarily initiated by its Vascular Solutions, Inc.

Teleflex To Showcase Key Anesthesia Products At Euroanaesthesia 2017 ("ESA") In Geneva

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for Critical Care, Urology and Surgery, will showcase the LMA® Protector™ and other key products in its Anesthesia portfolio, together...

Teleflex To Present At The 38th Annual Goldman Sachs Global Healthcare Conference

Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 38 th Annual Goldman Sachs Global Healthcare Conference at the Terranea Resort, Rancho...

Teleflex To Introduce The New Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump And The Product Portfolio From The Recently Acquired Vascular Solutions, Inc. At The European Association For Percutaneous Cardiovascular Interventions Course (EuroPCR)

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase its complex PCI product portfolio recently acquired from the purchase of Vascular...

Teleflex (TFX) Announces Commencement Of Phase I Clinical Study (FDP-1) Of RePlas™ Freeze-Dried Plasma

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced the commencement of the Phase I clinical study of RePlas, a lyophilized fresh frozen plasma...

Short Interest Drops 15.6% For TFX

The most recent short interest data has been released for the 04/28/2017 settlement date, which shows a 386,463 share decrease in total short interest for Teleflex Incorporated , to 2,088,000, a decrease of 15.62% since 04/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Teleflex Quarterly Dividend - Correction Of Record Date

Teleflex Incorporated (NYSE: TFX) announced that the record date for its regular quarterly dividend announced earlier today is the close of business May 18, 2017, rather than May 15, 2017.

Teleflex To Present At The 2017 UBS Global Healthcare Conference

Liam Kelly, President and COO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 2017 UBS Global Healthcare Conference at the Grand Hyatt New York, New York, NY, on Monday, May 22, 2017 at 11:00 a.

Teleflex Announces Quarterly Dividend

Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.

Teleflex Reports First Quarter 2017 Results

Teleflex Incorporated (NYSE: TFX) (the "Company") today announced financial results for the first quarter ended April 2, 2017.

Teleflex To Present At The Bank Of America Merrill Lynch 2017 Health Care Conference

Liam Kelly, President and COO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Merrill Lynch 2017 Health Care Conference at the Encore at Wynn Las Vegas, Las Vegas, Nevada, on Wednesday, May...

Teleflex Receives FDA 510(k) Clearance For The Arrow® AC3 OptimusTM Intra-Aortic Balloon Pump (IABP)

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced 510(k) clearance from the U.

Teleflex Announces First Quarter 2017 Earnings Conference Call Information

Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2017 will be released before market open on Thursday, May 4, 2017.

Teleflex Introduces The AsthmaMDTM Peak Flow Meter

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced its launch of the AsthmaMD TM Peak Flow Meter designed to help asthma patients to track and...

Teleflex Completes Acquisition Of Pyng Medical Corp.

Teleflex Medical Canada Inc. (" Teleflex Canada"), a wholly owned indirect subsidiary of Teleflex Incorporated (NYSE:TFX), today announced the completion of the acquisition of Pyng Medical Corp.

Teleflex (TFX) Announces 510(k) Clearance And Global Launch Of Twin-Pass® Torque Dual Access Catheter

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced 510(k) clearance by the Food and Drug Administration and both U.

Teleflex (TFX) Announces 510(k) Clearance And U.S. Launch Of Spectre™ Guidewire

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced 510(k) clearance by the Food and Drug Administration and U.

Teleflex To Present At Barclays Global Healthcare Conference

Benson Smith, Chairman and Chief Executive Officer, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami, Florida, on Tuesday, March 14,...

Teleflex Announces Quarterly Dividend

Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.

Teleflex Reports Fourth Quarter And Full Year 2016 Results; Provides 2017 Guidance

Teleflex Incorporated (NYSE: TFX) (the "Company") today announced financial results for the fourth quarter and year ended December 31, 2016.

TheStreet Quant Rating: A+ (Buy)